# Syntonix Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/syntonix-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Waltham, US
- Total disclosed funding: $48M
- Latest round: Series B (Apr 16, 2002)
- Investors on record: 9

## About

Syntonix Pharmaceuticals is a US based pharmaceuticals company.

## Funding rounds

- Series B, Apr 16, 2002, $36M — Alta Partners, BancBoston Capital - PEP, Venrock, Bay City Capital, A. M. Pappas & Associates, Merrill Lynch Ventures, Global Biomedical Partners
- Series A, Mar 15, 2000, $12M — BancBoston Capital - PEP, Venrock, Merrill Lynch & Co., Bayview 2000

## Investors

- BancBoston Capital - PEP (https://capitalatlas.ai/funds/bancboston-capital-pep) — Series A, Series B
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A, Series B
- Merrill Lynch & Co. — Series A
- Bayview 2000 — Series A
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series B
- A. M. Pappas & Associates — Series B
- Merrill Lynch Ventures — Series B
- Global Biomedical Partners — Series B